Michael Taylor
Förmögenhet: - $ per 2026-08-31
Förmögenhet: - $ per 2026-08-31
Mr. Michael Taylor is an Independent Director at NRX Pharmaceuticals, Inc. He is on the Board of Directors at NRX Pharmaceuticals, Inc. Mr. Taylor was previously employed as a Partner by Adi Dassler International Family Office LLC, a Managing Director by Oppenheimer & Co., Inc., and a MD-Institutional Fixed Income Trading by Stone & Youngberg LLC.
He received his undergraduate degree from London School of Economics & Political Science.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-02-12 | 0 ( -.--% ) | - $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| NRX PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2025-01-15 |
| Företag | Position | Slut |
|---|---|---|
Adi Dassler International Family Office LLC | Företagsledare/Principal | 2023-02-14 |
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Företagsledare/Principal | 2016-08-01 |
Stone & Youngberg LLC
Stone & Youngberg LLC Investment Banks/BrokersFinance Provides brokerage services | Företagsledare/Principal | 2011-06-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Finance |
Stone & Youngberg LLC
Stone & Youngberg LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
London School of Economics & Political Science
London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adi Dassler International Family Office LLC | |
NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a molecule pharmaceutical company | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån